P04626 (ERBB2_HUMAN) Homo sapiens (Human)

Receptor tyrosine-protein kinase erbB-2 UniProtKBInterProSTRINGInteractive Modelling

1255 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; Isoform 4; Isoform 5; Isoform 6); 1 identical sequence: Homo sapiens: X5DNK3

Available Structures

39 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Cryo-EM structure of Her2 extracellular domain-Trastuzumab Fab-Pertuzumab Fab complex Heteromer
P01834; P0DOX5; Q6GMX6;
23-644
NAG;NAG;
Assess
Crystallographic trimer of HER2 extracellular regions in complex with tryptophan-rich antibody frag… Heteromer
23-642
NAG;NAG;CL; 48×SO4;
Assess
HuA21-scFv in complex with the extracellular domain(ECD) of HER2 Heteromer
22-639
NAG;BMA;
Assess
Crystal structure of extracellular domain of human HER2 complexed with Herceptin Fab Heteromer
23-629
NAG;SO4;
Assess
Structure of Trastuzumab Fab mutant in complex with Her2 extracellular domain Heteromer
P0DOX5; Q7Z3Y4;
23-629
NAG;
Assess
Dual specific bH1 Fab in complex with the extracellular domain of HER2/ErbB-2 Heteromer
23-629
NAG;MES;
Assess
Structure of the HER2/HER3/NRG1b Heterodimer Extracellular Domain bound to Trastuzumab Fab Heteromer
P21860; Q02297;
24-629
NAG;NAG;NAG;
Assess
HER2 extracelluar region with affinity matured 3-helix affibody ZHER2:342 Heteromer
P38507;
23-600
NAG;NAG;
Assess
Crystal structure of extracellular domain of HER2 in complex with Fcab STAB19 Heteromer
P01857;
23-598
NAG;NAG;GOL;NAG;
Assess
39S Fab bound to HER2 ecd Heteromer
23-597
NAG;NAG;
Assess
Crystal structure of extracellular domain of HER2 in complex with Fcab H10-03-6 Heteromer
P01857;
23-597
Assess
Crystal structure of a HER2-Nb complex Heteromer
24-597
NAG;NAG;GOL;
Assess
Molecular Architecture of the ErbB2 Extracellular Domain Homodimer Heteromer
23-586
NAG;
Assess
Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex Heteromer
Q7Z3Y4;
23-586
NAG;NAG;
Assess
Structure of HER2 with an Fab Heteromer
23-586
Assess
HER2 in complex with Fab MF3958 Heteromer
23-564
NAG;NAG;NAG;
Assess
NM-02 in complex with HER2-ECD Heteromer
24-541
NAG;NAG;
Assess
Crystal structure of the single-chain Fv (scFv) fragment of an anti-ErbB2 antibody chA21 in complex… Heteromer
23-214
Assess
Structural Basis for Eliciting a Cytotoxic Effect in HER2-Overexpressing Cancer Cells via Binding t… Heteromer
24-213
Assess
Structural Basis for Eliciting a Cytotoxic Effect in HER2-Overexpressing Cancer Cells via Binding t… Heteromer
24-213
Assess
Crystal structure of HER2 Domain IV and Rb-H2 Heteromer
531-601
NAG;
Assess
Structural Basis for Eliciting a Cytotoxic Effect in HER2-Overexpressing Cancer Cells via Binding t… Heteromer
531-601
Assess
Heterodimeric association of Transmembrane domains of ErbB1 and ErbB2 receptors Enabling Kinase Act… Heteromer
P00533;
641-684
Assess
Solution structure of the human Grb7-SH2 domain in complex with a 10 amino acid peptide pY1139 Heteromer
Q14451;
1135-1144
Assess
Water refined solution structure of the human Grb7-SH2 domain in complex with the 10 amino acid pep… Heteromer
Q14451;
1135-1144
Assess
The Structure of ERBIN PDZ domain bound to the Carboxy-terminal tail of the ErbB2 Receptor Heteromer
Q96RT1;
1247-1255
Assess
POOR BINDING OF A HER-2/NEU EPITOPE (GP2) TO HLA-A2.1 IS DUE TO A LACK OF INTERACTIONS IN THE CENTE… Heteromer
P04439; P61769;
654-662
Assess
PTPN18 in complex with HER2-pY1248 phosphor-peptides Heteromer
Q99952;
1246-1252
Assess
Phospholipase C gamma-1 C-terminal SH2 domain bound to a phosphopeptide derived from the receptor t… Heteromer
P08487;
1220-1225
Assess
Structural basis of PTPN18 fingerprint on distinct HER2 tyrosine phosphorylation sites Heteromer
Q99952;
1109-1114
Assess
The Structure of ERBIN PDZ domain bound to the Carboxy-terminal tail of the ErbB2 Receptor Heteromer
Q96RT1;
1251-1255
Assess
Spatial structure of HER2/ErbB2 dimeric transmembrane domain in the presence of cytoplasmic juxtame…homo-2-mer644-700
Assess
NMR spatial structure of HER2 TM domain dimer in DPC micelles.homo-2-mer641-684
Assess
ErbB2 transmembrane segment dimer spatial structurehomo-2-mer641-684
Assess
Crystal structure of ErbB2 domains 1-3monomer22-530
NAG;NAG;
Assess
HER2 Kinase Domain Complexed with TAK-285monomer713-1022
03P;
Assess
HER2 in complex with JBJ-08-178-01monomer707-996
VOY;
Assess
Crystal Structure of the Kinase domain of Human HER2 (erbB2).monomer706-993
03Q;
Assess
HER2 IN COMPLEX WITH A COVALENT INHIBITORmonomer710-991
70I;
Assess

2 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
6bgt.1.Amonomer0.8023-629
NAG;100.00
Assess
3bbt.1.Amonomer0.69710-999
FMM;72.90
Assess

9 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 23pp0.2.Amonomer0.7596-399
03Q;98.18
Assess
Isoform 27mn8.1.Cmonomer0.603-19
99.76
Assess
Isoform 34riy.2.Bmonomer0.7710-305
ADP;77.94
Assess
Isoform 46bgt.1.Amonomer0.808-614
NAG;99.06
Assess
Isoform 43bbt.1.Amonomer0.69695-984
FMM;72.81
Assess
Isoform 57mn8.1.Cmonomer0.791-599
99.80
Assess
Isoform 53bbt.1.Amonomer0.69680-969
FMM;72.90
Assess
Isoform 57syd.1.Cmonomer0.682-614
53.13
Assess
Isoform 67mn5.1.Cmonomer0.8124-629
94.18
Assess